Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-Viral Therapy With and Without Maternal CMV CTLs in Neonates With CMV Infection
NCT05564598Phase 2Recruiting
- Sponsor
- New York Medical College
- Start
- Jul 2023
- Primary completion
- Oct 2027
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of cytomegalovirus-specific cytotoxic T lymphocytes in congenital cytomegalovirus infection (cCMV), sponsored by New York Medical College. Started Jul 2023; status: recruiting.
02
Drugs
cytomegalovirus-specific cytotoxic T lymphocytes
03
Conditions
congenital cytomegalovirus infection (cCMV)
Beyond the preview
Go deeper on NCT05564598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05564598.